Search

everythinglearnresearchcommunity

for

Search:↓

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Milk thistle can protect skin from damage and aging.

Korean Red Ginseng saponins may protect skin from inflammation and darkening caused by air pollution.

Older age increases positive hair alcohol test results, and chest hair is a good alternative for testing; season affects results, with higher levels in winter.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Higher early lead exposure is linked to delayed puberty in girls.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Prenatal pesticide exposure may cause earlier breast development in girls.

The DLQI is a key tool for measuring quality of life in dermatology.

Polymenorrhoea should be included in PCOS diagnostic criteria due to similar metabolic issues.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Telogen effluvium most affects quality of life in alopecia patients.

Diabetes may lower the risk of prostate cancer.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Topical steroids help Erosive Lichen Planus, finasteride with birth control aids Female Pattern Hair Loss, young age helps Occupational Hand Eczema prognosis, quitting smoking is key for Diffuse Dermal Angiomatosis, and a 3-site Botulinum Toxin A injection is effective for glabellar wrinkles.

The dual-serum cosmetic system effectively improves hair loss in women.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

The study successfully gathered a diverse group of 438 women to understand the prevalence of polycystic ovary syndrome, with most participants recruited online and at community fairs.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

SOD1 and KL are promising targets for new hair loss treatments.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.